In: Biology
Matching
1. |
Astrocytes |
A. Sheet-like cancer of epithelial origin |
2. |
Immortality |
B. Can cause senescence in dividing cells |
3. |
Squamous carcinoma |
C. Increases risk of breast cancer |
4. |
Metaplasia (example) |
D. Decreases risk of breast cancer |
5. |
Adenocarcinoma |
E. Associated with stomach cancer incidence patterns |
6. |
Having no natural-born children |
F. Can affect cell shape, cell adhesion, and cell motility |
7. |
Over-expression or mis-expression of a receptor on breast cancer cells |
G. Supporting cells in the brain |
8. |
aneuploidy |
H. Can cross-link receptors in the membrane of a cell |
9. |
Helicobacter pylori infection |
I. Neoplasm brain tissue origin |
10. |
Shortening of telomeres |
J. Neoplasm of striated muscle cell origin |
11. |
Leading cause of cancer deaths in women |
K. Can lead to activation of cancer-causing genes |
12. |
Astrocytoma or glioblastoma |
L. The lymphatic system |
13. |
cytoskeletal anaplasia |
M. Can have early onset multifocal incidence pattern |
14. |
Bilateral retinoblastoma |
N. Phenotypic characteristic of many cancer cells in culture |
15. |
Genomic instability and selection |
O. Hepatitis B Virus |
16. |
Onco-fetal gene products |
P. Sac-like or glandular neoplasm of epithelial cell origin |
17. |
Bivalent growth factors |
Q. Ewing's sarcoma |
18. |
Can lead to hepatocellular carcinoma |
R. Can lead to drug resistance during treatment |
19. |
Genetic drift |
S. Ciliated epithelium replaced by squamous epithelium |
20. |
Lower dietary fat and body mass |
T. Abnormal number and form of chromosomes |
21. |
Rhabdomyosarcoma |
U. Can happen when cell lines are passaged repeatedly |
22. |
Fusion protein gene product |
V. Often re-expressed in cancer cells |
23. |
Protease inhibitors |
W. Target for Herceptin |
24. |
Route of metastatic spread |
X. Lung cancer |
25. |
form of bone cancer |
Y. Might inhibit invasion |
1. |
Astrocytes |
G. Supporting cells in the brain. |
2. |
Immortality |
N. Phenotypic characteristic of many cancer cells in culture |
3. |
Squamous carcinoma |
A. Sheet-like cancer of epithelial origin |
4. |
Metaplasia (example) |
S. Ciliated epithelium replaced by squamous epithelium |
5. |
Adenocarcinoma |
P. Sac-like or glandular neoplasm of epithelial cell origin |
6. |
Having no natural-born children |
C. Increases risk of breast cancer |
7. |
Over-expression or mis-expression of a receptor on breast cancer cells |
W. Target for Herceptin |
8. |
aneuploidy |
T. Abnormal number and form of chromosomes |
9. |
Helicobacter pylori infection |
E. Associated with stomach cancer incidence patterns |
10. |
Shortening of telomeres |
B. Can cause senescence in dividing cells |
11. |
Leading cause of cancer deaths in women |
X. Lung cancer |
12. |
Astrocytoma or glioblastoma |
I. Neoplasm brain tissue origin |
13. |
cytoskeletal anaplasia |
F. Can affect cell shape, cell adhesion, and cell motility |
14. |
Bilateral retinoblastoma |
M. Can have early onset multifocal incidence pattern |
15. |
Genomic instability and selection |
K. Can lead to activation of cancer-causing genes |
16. |
Onco-fetal gene products |
R. Can lead to drug resistance during treatment |
17. |
Bivalent growth factors |
H. Can cross-link receptors in the membrane of a cell |
18. |
Can lead to hepatocellular carcinoma |
O. Hepatitis B Virus |
19. |
Genetic drift |
U. Can happen when cell lines are passaged repeatedly |
20. |
Lower dietary fat and body mass |
D. Decreases risk of breast cancer |
21. |
Rhabdomyosarcoma |
J. Neoplasm of striated muscle cell origin |
22. |
Fusion protein gene product |
V. Often re-expressed in cancer cells |
23. |
Protease inhibitors |
Y. Might inhibit invasion |
24. |
Route of metastatic spread |
L. The lymphatic system |
25. |
form of bone cancer |
Q. Ewing's sarcoma |